Approval · Notice of Compliance 28154 · 2022
IMODIUM COMPLETE: Notice of Compliance 28154
Issued May 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28154
- Date
- May 13, 2022
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the Product Monograph. Revisions to the product monograph. Update to the Package Insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMODIUM COMPLETE | 02245185 | Marketed |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB
- SIMETHICONE 125 MG per TAB